GABPX
Price
$48.75
Change
-$0.50 (-1.02%)
Updated
Feb 21 closing price
Net Assets
419M
RMFCX
Price
$57.23
Change
-$0.62 (-1.07%)
Updated
Feb 21 closing price
Net Assets
105.48B
Ad is loading...

GABPX vs RMFCX

Header iconGABPX vs RMFCX Comparison
Open Charts GABPX vs RMFCXBanner chart's image
Goldman Sachs Equity Income P
Price$48.75
Change-$0.50 (-1.02%)
VolumeN/A
Net Assets419M
American Funds American Mutual R3
Price$57.23
Change-$0.62 (-1.07%)
VolumeN/A
Net Assets105.48B
GABPX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GABPX vs. RMFCX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GABPX is a StrongBuy and RMFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 105B vs. GABPX (419M). GABPX (1.76) and RMFCX (1.69) have matching dividends . GABPX was incepted earlier than RMFCX: GABPX (7 years) vs RMFCX (23 years). GABPX is a more actively managed with annual turnover of: 32.00 vs. RMFCX (25.00). GABPX has a lower initial minimum investment than RMFCX: GABPX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 11.03 vs. GABPX (8.95). RMFCX return over 5 years is better than : 41.75 vs. GABPX (27.49).
GABPXRMFCXGABPX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years23 years-
Gain YTD4.4574.83692%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets419M105B0%
Annual Yield % from dividends1.761.69104%
Returns for 1 year8.9511.0381%
Returns for 3 years15.3619.6978%
Returns for 5 years27.4941.7566%
Returns for 10 yearsN/A64.83-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVRI13.810.01
+0.07%
Everi Holdings
YETI36.83-0.08
-0.22%
YETI Holdings
GNFT3.83-0.09
-2.30%
Genfit SA
CTXR1.80-0.05
-2.70%
Citius Pharmaceuticals Inc
AER101.67-4.11
-3.89%
Aercap Holdings NV